Identifying and Prioritising Gaps in Neuroendocrine Tumour Research - Results of the Delphi Consensus Project of the Commonwealth Neuroendocrine Tumour Research Collaboration (CommNETS) Abstract #1358

Introduction: The newly formed CommNETS group used the robust Delphi methodology with broad stakeholder engagement to form a strategic research agenda.
Aim(s): To identify gaps in NET research and develop research priorities.
Materials and methods: A 3 round Delphi (2 online surveys plus final round at the Inaugural CommNETS meeting) was performed with wide participation from stakeholders including subject experts (medical, nursing, scientific) and consumers (patients, families, advocates). Round 1 identified gaps in NET research and CommNETs’ strengths compared to USA & Europe; Round 2 identified research priorities; Round 3 ranked priorities after extensive workshops and established project groups.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: ...none of the above
Presenting Author: A/P Eva Segelov

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1366 CommNETS: Formation of an International Commonwealth Countries NET Partnership
Introduction: Neuroendocrine tumours (NETs) care is challenging in Canada, Australia and New Zealand due to small populations in large geographical space, limited drug funding, and lack of NET awareness. There is a need for collaboration to focus research and improve care and outcomes for NET patients in these nations with similar health systems.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: ...none of the above
Presenting Author: Dr. Simron Singh
Authors: Singh S, Lawrence B, Chan D, Pavlakis N, ...
Keywords: research, society
#318 The SEER as a Prophet: Epidemiological Analysis as a Harbinger of Evolving Priorities in Gastroenteropancreatic Neuroendocrine Neoplasia
Introduction: Previous epidemiology analysis of tumor registries established that gastroenteropancreatic neuroendocrine neoplasms (GEP-NETs) were both more prevalent, and more malignant, than previously recognized.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Dr. Mark Kidd
#1310 Current Trials in Neuroendocrine Tumours: A Systematic Review
Introduction: Trials in neuroendocrine tumours (NETs) have increased markedly in number over the last 10 years. Researchers do not have ready access to a summary of open trials to identify research gaps.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: ...none of the above
Presenting Author: Dr David Chan
Authors: Chan D, Segelov E, Millican J, Singh S, ...
Keywords: trials, review
#1920 Optimising Followup after Complete Surgical Resection of Gastrointestinal Neuroendocrine Tumours- A Delphi Process to Produce Expert Consensus in an Area Lacking Clinical Evidence
Introduction: Optimal follow-up for completely resected GI-NETS has not been well defined, with heterogeneity in awareness and application of existing guidelines.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: ...none of the above
Presenting Author: Lesley Moody
Authors: Moody L, Segelov E, Chan D, Carsley S, ...
Keywords: RAM, NET
#160 The role of T-type calcium channels in medullary thyroid carcinoma (MTC): T-type calcium channel blockers inhibit hormone secretion and induce apoptotic cell death in a human MTC cell line
Introduction: Medullary thyroid carcinoma (MTC) accounts for approximately 5-10% of thyroid cancers. In the case of tumors limited to the thyroid gland, the prognosis is generally favorable, whereas 5-year survival averages only 40% in patients with metastatic disease. In these patients, conventional chemotherapy only occasionally leads to a complete response and partial responses are observed in less than 30% of the cases. Therefore, intense efforts are currently directed toward the identification of new druggable targets for the treatment of this devastating disease.
Conference: 7th Annual ENETS Conference (2010)
Category: Basic
Presenting Author: Dr Rosario Pivonello